TrialCancer immunology, immunotherapy : CII2006

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.

Ying Waeckerle-Men et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.